ApoA-IV Monoclonal Antibody
- Catalog No.:YM0032
- Applications:WB;ELISA
- Reactivity:Human
- Target:
- ApoA-IV
- Fields:
- >>Fat digestion and absorption;>>Vitamin digestion and absorption;>>Cholesterol metabolism;>>Lipid and atherosclerosis
- Gene Name:
- APOA4
- Protein Name:
- Apolipoprotein A-IV
- Human Gene Id:
- 337
- Human Swiss Prot No:
- P06727
- Mouse Swiss Prot No:
- P06728
- Immunogen:
- Purified recombinant fragment of ApoA-IV (aa21-396) expressed in E. Coli.
- Specificity:
- ApoA-IV Monoclonal Antibody detects endogenous levels of ApoA-IV protein.
- Formulation:
- Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
- Source:
- Monoclonal, Mouse
- Dilution:
- WB 1:500 - 1:2000. ELISA: 1:10000. Not yet tested in other applications.
- Purification:
- Affinity purification
- Storage Stability:
- -15°C to -25°C/1 year(Do not lower than -25°C)
- Other Name:
- APOA4;Apolipoprotein A-IV;Apo-AIV;ApoA-IV;Apolipoprotein A4
- Molecular Weight(Da):
- 45kD
- References:
- 1. J Biol Chem. 2006 Feb 10;281(6):3560-8.
2. Clin Chim Acta. 2008 Feb;388(1-2):78-83.
- Background:
- Apoliprotein (apo) A-IV gene contains 3 exons separated by two introns. A sequence polymorphism has been identified in the 3'UTR of the third exon. The primary translation product is a 396-residue preprotein which after proteolytic processing is secreted its primary site of synthesis, the intestine, in association with chylomicron particles. Although its precise function is not known, apo A-IV is a potent activator of lecithin-cholesterol acyltransferase in vitro. [provided by RefSeq, Jul 2008],
- Function:
- domain:Nine of the thirteen 22-amino acid tandem repeats (each 22-mer is actually a tandem array of two, A and B, related 11-mers) occurring in this sequence are predicted to be highly alpha-helical, and many of these helices are amphipathic. They may therefore serve as lipid-binding domains with lecithin:cholesterol acyltransferase (LCAT) activating abilities.,function:May have a role in chylomicrons and VLDL secretion and catabolism. Required for efficient activation of lipoprotein lipase by ApoC-II; potent activator of LCAT. Apoa-IV is a major component of HDL and chylomicrons.,online information:The Singapore human mutation and polymorphism database,polymorphism:Eight alleles have been characterized (APOA-IV*0 to APOA-IV*7). APOA-IV*1 is the major allele (90%), APOA-IV*2 is also common (8%), the others are rare alleles.,similarity:Belongs to the apolipoprotein A1/A4/E family.,tissue
- Subcellular Location:
- Secreted.
- Expression:
- Synthesized primarily in the intestine and secreted in plasma.
- June 19-2018
- WESTERN IMMUNOBLOTTING PROTOCOL
- June 19-2018
- IMMUNOHISTOCHEMISTRY-PARAFFIN PROTOCOL
- June 19-2018
- IMMUNOFLUORESCENCE PROTOCOL
- September 08-2020
- FLOW-CYTOMEYRT-PROTOCOL
- May 20-2022
- Cell-Based ELISA│解您多样本WB检测之困扰
- July 13-2018
- CELL-BASED-ELISA-PROTOCOL-FOR-ACETYL-PROTEIN
- July 13-2018
- CELL-BASED-ELISA-PROTOCOL-FOR-PHOSPHO-PROTEIN
- July 13-2018
- Antibody-FAQs
- Products Images
- Western Blot analysis using ApoA-IV Monoclonal Antibody against truncated APOA4-His recombinant protein (1),truncated APOA4(aa21-396)-hIgGFc transfected CHO-K1 cell lysate(2),human serum (3) and human plasma (4).